Eli Lilly, a pharmaceutical company, has declared it is funding one more $5.3 billion in an manufacturing plant in Lebanon, Indiana, to support the assembling of its exceptionally famous weight reduction drug Zepbound, diabetes treatment Mounjaro...
The US Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to lead clinical candidate VCN-01 in combination with gemcitabine and nab-paclitaxel to improve progression-free survival and overall survival in patients with...
Oxford Nanopore Technologies (Oxford Nanopore) has announced the introduction of a new Pharmacogenomics (PGx) Beta Programme to promote personalized medicine. The program combines Twist Bioscience's next generation sequencing (NGS) target...
Biocon Ltd said it has marked a exclusive licensing and supply concurrence with South Korea's Handok for commercialisation of its complex drug product, synthetic Liraglutide, utilized in the therapy of constant weight management. As per the...
Nona Biosciences, a worldwide biotechnology firm that offers a complete solution from “Idea to IND” (I to ITM), going from target approval and neutralizer disclosure through preclinical exploration, reported that it has gone into a license...
SAB Biotherapeutics, a clinical-stage biopharmaceutical firm, stated that the US Food and Drug Administration (FDA) has approved the company's investigational new drug (IND) application to move on with its phase 1 clinical study for type 1...
.jpg)
